1. Connecting imaging mass spectrometry and magnetic resonance imaging-based anatomical atlases for automated anatomical interpretation and differential analysis. Verbeeck N, Spraggins JM, Murphy MJM, Wang HD, Deutch AY, Caprioli RM, Van de Plas R (2017) Biochim Biophys Acta Proteins Proteom 1865(7): 967-977
    › Primary publication · 28254588 (PubMed)
  2. Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue. Jovanović B, Sheng Q, Seitz RS, Lawrence KD, Morris SW, Thomas LR, Hout DR, Schweitzer BL, Guo Y, Pietenpol JA, Lehmann BD (2017) BMC Cancer 17(1): 241
    › Primary publication · 28376728 (PubMed) · PMC5379658 (PubMed Central)
  3. Collagen IV and basement membrane at the evolutionary dawn of metazoan tissues. Fidler AL, Darris CE, Chetyrkin SV, Pedchenko VK, Boudko SP, Brown KL, Gray Jerome W, Hudson JK, Rokas A, Hudson BG (2017) Elife
    › Primary publication · 28418331 (PubMed) · PMC5395295 (PubMed Central)
  4. Chronic β-Cell Depolarization Impairs β-Cell Identity by Disrupting a Network of Ca-Regulated Genes. Stancill JS, Cartailler JP, Clayton HW, O'Connor JT, Dickerson MT, Dadi PK, Osipovich AB, Jacobson DA, Magnuson MA (2017) Diabetes 66(8): 2175-2187
    › Primary publication · 28550109 (PubMed) · PMC5521870 (PubMed Central)
  5. Building collagen IV smart scaffolds on the outside of cells. Brown KL, Cummings CF, Vanacore RM, Hudson BG (2017) Protein Sci 26(11): 2151-2161
    › Primary publication · 28845540 (PubMed) · PMC5654846 (PubMed Central)
  6. Both Drosophila matrix metalloproteinases have released and membrane-tethered forms but have different substrates. LaFever KS, Wang X, Page-McCaw P, Bhave G, Page-McCaw A (2017) Sci Rep : 44560
    › Primary publication · 28300207 (PubMed) · PMC5353688 (PubMed Central)
  7. Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function. Pellom ST, Dudimah DF, Thounaojam MC, Uzhachenko RV, Singhal A, Richmond A, Shanker A (2017) Oncotarget 8(5): 8604-8621
    › Primary publication · 28052005 (PubMed) · PMC5352426 (PubMed Central)
  8. A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67. Jovanović B, Mayer IA, Mayer EL, Abramson VG, Bardia A, Sanders ME, Kuba MG, Estrada MV, Beeler JS, Shaver TM, Johnson KC, Sanchez V, Rosenbluth JM, Dillon PM, Forero-Torres A, Chang JC, Meszoely IM, Grau AM, Lehmann BD, Shyr Y, Sheng Q, Chen SC, Arteaga CL, Pietenpol JA (2017) Clin Cancer Res 23(15): 4035-4045
    › Primary publication · 28270498 (PubMed) · PMC5540799 (PubMed Central)
  9. An Acquired Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer. Hanker AB, Brewer MR, Sheehan JH, Koch JP, Sliwoski GR, Nagy R, Lanman R, Berger MF, Hyman DM, Solit DB, He J, Miller V, Cutler RE, Lalani AS, Cross D, Lovly CM, Meiler J, Arteaga CL (2017) Cancer Discov 7(6): 575-585
    › Primary publication · 28274957 (PubMed) · PMC5457707 (PubMed Central)
  10. A mechanically coupled reaction-diffusion model that incorporates intra-tumoural heterogeneity to predict glioma growth. Hormuth DA, Weis JA, Barnes SL, Miga MI, Rericha EC, Quaranta V, Yankeelov TE (2017) J R Soc Interface 14(128)
    › Primary publication · 28330985 (PubMed) · PMC5378136 (PubMed Central)